Management of nonviral mixed cryoglobulinemia vasculitis refractory to rituximab: Data from a European collaborative study and review of the literature
Clara Pouchelon(Hôpital Cochin), Benjamin Terrier(Hôpital Cochin), Milvia Casato(Sapienza University of Rome), T. Moulinet(Centre National de la Recherche Scientifique), M. Jachiet(Assistance Publique – Hôpitaux de Paris), M. Samson(CHU Dijon Bourgogne), Véronique Le Guern(Délégation Paris 5), Mikaël Ebbo(Aix-Marseille Université), Stanislas Faguer(Hôpital Rangueil), Antoine Briantais(Aix-Marseille Université), Luca Quartuccio(Ospedale Santa Maria della Misericordia di Udine), Marcella Visentini(Istituto Pasteur), Marie Chilles(Université d'Orléans), María C. Cid(Fundació Clínic per a la Recerca Biomèdica), Giacomo Emmi(Ospedale di Cattinara), Renato Alberto Sinico(Istituti di Ricovero e Cura a Carattere Scientifico), Emmanuel Chatelus(Laboratoire National de Référence), Bernhard Hellmich(University Children's Hospital Tübingen), F. Perrin(Centre Hospitalier Saint-Nazaire), Élisabeth Diot(Centre Hospitalier Universitaire de Tours), T. Quéméneur(Centre Hospitalier de Valenciennes), Nils Venhoff(University Medical Center Freiburg)
Cited by 21
Related Papers
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
|Arthritis & Rheumatism|2012|6.6k
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
2018 Update of the EULAR recommendations for the management of large vessel vasculitis
|Annals of the Rheumatic Diseases|2019|1.1k
Randomized Trial of Plasma Exchange or High-Dosage Methylprednisolone as Adjunctive Therapy for Severe Renal Vasculitis
|Journal of the American Society of Nephrology|2007|1.1k